SCHEMBL7489209

SCHEMBL7489209

NCC(O)Cc1ccc2c(c1)OCO2

nearest known ligand 0.73

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.73
▸ SLC6A4 P31645 3/20 0.65
▸ TAAR1 Q96RJ0 4/20 0.61
▸ SLC6A2 P23975 2/20 0.61
▸ SLC6A3 Q01959 2/20 0.61
▸ CYP2D6 P10635 2/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.52
▸ GAA P10253 3/20 0.48
▸ MAPT P10636 2/20 0.48
▸ ATM Q13315 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ ALOX12 P18054 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Safrolglycol SCHEMBL11447270 0.85 CYP3A4 (1.00) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3
Safrolglycol SCHEMBL7510518 0.85 CYP3A4 (1.00) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3
Safrolglycol SCHEMBL29368350 0.85 CYP3A4 (1.00) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3
SCHEMBL25183681 0.83 CYP3A4 (0.73) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3
SCHEMBL19354484 0.83 CYP3A4 (0.73) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3
SCHEMBL25190612 0.83 CYP3A4 (0.73) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3
SCHEMBL8515123 0.83 SLC6A4 (0.74) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3
SCHEMBL23016555 0.82 CYP3A4 (0.72) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3
SCHEMBL28067489 0.82 CYP3A4 (0.71) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3
SCHEMBL8416219 0.81 SLC6A4 (0.83) CYP3A4SLC6A4TAAR1SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105792670-B Organic compounds 奇华顿股份有限公司 2021-02-05 — — CN disclosed
EP-0825189-B1 1,4-BENZODIOXIN DERIVATIVES NISSHIN PHARMA INC (JP) 2002-01-02 — — EP disclosed
US-6130243-A PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES, HYPERGLYCEMIA AND OBESITY IN MAMMALS NISSHIN FLOUR MILLING CO., LTD. (JP) 2000-10-10 — — US disclosed
EP-0825189-A1 1,4-BENZODIOXIN DERIVATIVES NISSHIN FLOUR MILLING CO., LTD. (JP) 1998-02-25 — — EP disclosed
Send feedback